The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term ...

Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” ...

Experimenting on animals is a dark side of science and research. And most of us try not to think about the animals that experienced the horrors of testing when we buy medicine or cleaning supplies. I ...

Animal models work in lab conditions, because their lives are shorter so you can control the environment in studies.

Animal testing for new drugs is being phased out because of advances made in artificial intelligence (AI), the UK's medicines ...

Discover the MHRA's commitment to phasing out animal testing in the UK and adopting innovative alternatives for drug safety ...

Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...